BioLabs New Haven reposted this
🌟 Exciting news from BioLabs San Diego! 🌟 We're thrilled to share that one of our very own resident companies, CellarisBio, is launching its first-ever Challenging Target Award. This award aims to empower life science startups tackling complex drug targets. It is a fantastic opportunity to de-risk and accelerate drug discovery efforts! If you're developing targeted therapies and want to take your project to the next level, don’t miss out! Apply using the link below! This is a great example of how collaboration and innovation can drive breakthroughs in drug development. Let's support our local companies pushing the boundaries of science! #Biotech #Pharma #DrugDiscovery #LifeScience #ChallengingTargets #MICROTAG #CellarisBio #InnovativeTherapies #SanDiegoBiotech
We are excited to announce our first-time Challenging Target Award. Are you working on a challenging drug target for future targeted therapy? Our Challenging Target Award program is tailored for life science startups aiming to de-risk and accelerate top-in-class drug discovery programs. Exclusive access to our MICRO-TAG platform awaits, supporting you through discovery, validation, and analysis of novel drug candidates for your specific target. We'll collaborate closely to position this data effectively for your investors and leadership. CellarisBio, a specialized drug discovery platform, focuses on challenging drug targets using cell target engagement within complex cellular environments. From hit ID to lead optimization, we guide programs by navigating chemical space, in-cell potency, selectivity, and mechanism-of-action, fast-tracking them to IND. The MICRO-TAG platform facilitates the discovery and validation of inhibitors, allosteric binders, molecular glues, degraders, and target stabilizers. Apply by November 1, 2024 at CellarisBio.com/Award Important dates: October 1st, 2024 – Applications open November 1st, 2024 – Applications close December 2nd, 2024 - Pitch by finalists December 16th, 2024 – Winners announced #Biotech #Pharma #DrugDiscovery #LifeScience #ChallengingTargets #MICROTAG #CellarisBio #DrugDevelopment #InnovativeTherapies #assaydevelopment #biophysics #invitroassays #cellularassays #immunooncology #molecularglues #HTS #targetedproteindegradation #biochemicalassays